A citation-based method for searching scientific literature

Rebecca G Pomerantz, Jennifer Rubin Grandis. Curr Oncol Rep 2003
Times Cited: 39







List of co-cited articles
268 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck.
James A Bonner, Paul M Harari, Jordi Giralt, Nozar Azarnia, Dong M Shin, Roger B Cohen, Christopher U Jones, Ranjan Sur, David Raben, Jacek Jassem,[...]. N Engl J Med 2006
25



Head and neck cancer.
A Forastiere, W Koch, A Trotti, D Sidransky. N Engl J Med 2001
17

Targeting epidermal growth factor receptor in head and neck cancer.
Allison Carter Ford, Jennifer Rubin Grandis. Head Neck 2003
101
15


Persistent activation of the Akt pathway in head and neck squamous cell carcinoma: a potential target for UCN-01.
Panomwat Amornphimoltham, Virote Sriuranpong, Vyomesh Patel, Fernando Benavides, Claudio J Conti, John Sauk, Edward A Sausville, Alfredo A Molinolo, J Silvio Gutkind. Clin Cancer Res 2004
135
15


Head and neck cancer.
E E Vokes, R R Weichselbaum, S M Lippman, W K Hong. N Engl J Med 1993
12

Levels of TGF-alpha and EGFR protein in head and neck squamous cell carcinoma and patient survival.
J Rubin Grandis, M F Melhem, W E Gooding, R Day, V A Holst, M M Wagener, S D Drenning, D J Tweardy. J Natl Cancer Inst 1998
849
12

Radiotherapy plus cetuximab for locoregionally advanced head and neck cancer: 5-year survival data from a phase 3 randomised trial, and relation between cetuximab-induced rash and survival.
James A Bonner, Paul M Harari, Jordi Giralt, Roger B Cohen, Christopher U Jones, Ranjan K Sur, David Raben, Jose Baselga, Sharon A Spencer, Junming Zhu,[...]. Lancet Oncol 2010
12

DNA content as a prognostic marker in patients with oral leukoplakia.
J Sudbø, W Kildal, B Risberg, H S Koppang, H E Danielsen, A Reith. N Engl J Med 2001
211
10

The influence of resection and aneuploidy on mortality in oral leukoplakia.
Jon Sudbø, Scott M Lippman, J Jack Lee, Li Mao, Wanja Kildal, Asle Sudbø, Simone Sagen, Magne Bryne, Adel El-Naggar, Björn Risberg,[...]. N Engl J Med 2004
77
10

Genetic progression model for head and neck cancer: implications for field cancerization.
J Califano, P van der Riet, W Westra, H Nawroz, G Clayman, S Piantadosi, R Corio, D Lee, B Greenberg, W Koch,[...]. Cancer Res 1996
10

Phase II trial of ZD1839 in recurrent or metastatic squamous cell carcinoma of the head and neck.
Ezra E W Cohen, Fred Rosen, Walter M Stadler, Wendy Recant, Kerstin Stenson, Dezheng Huo, Everett E Vokes. J Clin Oncol 2003
466
10



Cancer statistics, 2000.
R T Greenlee, T Murray, S Bolden, P A Wingo. CA Cancer J Clin 2000
10


Focus on head and neck cancer.
Li Mao, Waun K Hong, Vassiliki A Papadimitrakopoulou. Cancer Cell 2004
263
10

Mammalian target of rapamycin, a molecular target in squamous cell carcinomas of the head and neck.
Panomwat Amornphimoltham, Vyomesh Patel, Akrit Sodhi, Nikolaos G Nikitakis, John J Sauk, Edward A Sausville, Alfredo A Molinolo, J Silvio Gutkind. Cancer Res 2005
179
10


Impact of epidermal growth factor receptor expression on survival and pattern of relapse in patients with advanced head and neck carcinoma.
K Kian Ang, Brian A Berkey, Xiaoyu Tu, Hua-Zhong Zhang, Ruth Katz, Elizabeth H Hammond, Karen K Fu, Luka Milas. Cancer Res 2002
875
10

Open-label, uncontrolled, multicenter phase II study to evaluate the efficacy and toxicity of cetuximab as a single agent in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck who failed to respond to platinum-based therapy.
Jan B Vermorken, José Trigo, Ricardo Hitt, Piotr Koralewski, Eduardo Diaz-Rubio, Frédéric Rolland, Rainald Knecht, Nadia Amellal, Armin Schueler, José Baselga. J Clin Oncol 2007
653
10

Increased epidermal growth factor receptor gene copy number is associated with poor prognosis in head and neck squamous cell carcinomas.
Christine H Chung, Kim Ely, Loris McGavran, Marileila Varella-Garcia, Joel Parker, Natalie Parker, Carolyn Jarrett, Jesse Carter, Barbara A Murphy, James Netterville,[...]. J Clin Oncol 2006
417
10

Constitutive activation of Stat3 signaling abrogates apoptosis in squamous cell carcinogenesis in vivo.
J R Grandis, S D Drenning, Q Zeng, S C Watkins, M F Melhem, S Endo, D E Johnson, L Huang, Y He, J D Kim. Proc Natl Acad Sci U S A 2000
503
10

Mutant epidermal growth factor receptor (EGFRvIII) contributes to head and neck cancer growth and resistance to EGFR targeting.
John C Sok, Francesca M Coppelli, Sufi M Thomas, Miriam N Lango, Sichuan Xi, Jennifer L Hunt, Maria L Freilino, Michael W Graner, Carol J Wikstrand, Darell D Bigner,[...]. Clin Cancer Res 2006
352
10

Platinum-based chemotherapy plus cetuximab in head and neck cancer.
Jan B Vermorken, Ricard Mesia, Fernando Rivera, Eva Remenar, Andrzej Kawecki, Sylvie Rottey, Jozsef Erfan, Dmytro Zabolotnyy, Heinz-Roland Kienzer, Didier Cupissol,[...]. N Engl J Med 2008
10

Frequent microsatellite alterations at chromosomes 9p21 and 3p14 in oral premalignant lesions and their value in cancer risk assessment.
L Mao, J S Lee, Y H Fan, J Y Ro, J G Batsakis, S Lippman, W Hittelman, W K Hong. Nat Med 1996
404
7


Use of allelic loss to predict malignant risk for low-grade oral epithelial dysplasia.
M P Rosin, X Cheng, C Poh, W L Lam, Y Huang, J Lovas, K Berean, J B Epstein, R Priddy, N D Le,[...]. Clin Cancer Res 2000
300
7

Multiple oral squamous epithelial lesions: are they genetically related?
S J Jang, I Chiba, A Hirai, W K Hong, L Mao. Oncogene 2001
76
7

Telomerase activity in head and neck squamous cell carcinoma and adjacent tissues.
L Mao, A K El-Naggar, Y H Fan, J S Lee, S M Lippman, S Kayser, R Lotan, W K Hong. Cancer Res 1996
127
7

Epidermal growth factor-related peptides and their receptors in human malignancies.
D S Salomon, R Brandt, F Ciardiello, N Normanno. Crit Rev Oncol Hematol 1995
7

Flavopiridol, a novel cyclin-dependent kinase inhibitor, suppresses the growth of head and neck squamous cell carcinomas by inducing apoptosis.
V Patel, A M Senderowicz, D Pinto, T Igishi, M Raffeld, L Quintanilla-Martinez, J F Ensley, E A Sausville, J S Gutkind. J Clin Invest 1998
212
7

Oral cancer and precancerous lesions.
Brad W Neville, Terry A Day. CA Cancer J Clin 2002
697
7

Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer.
Arlene A Forastiere, Helmuth Goepfert, Moshe Maor, Thomas F Pajak, Randal Weber, William Morrison, Bonnie Glisson, Andy Trotti, John A Ridge, Clifford Chao,[...]. N Engl J Med 2003
7

Association between cigarette smoking and mutation of the p53 gene in squamous-cell carcinoma of the head and neck.
J A Brennan, J O Boyle, W M Koch, S N Goodman, R H Hruban, Y J Eby, M J Couch, A A Forastiere, D Sidransky. N Engl J Med 1995
500
7


Epidermal growth factor receptor blockade potentiates apoptosis mediated by Paclitaxel and leads to prolonged survival in a murine model of oral cancer.
F Christopher Holsinger, Dao D Doan, Samar A Jasser, Eric A Swan, Jayson S Greenberg, Bradley A Schiff, B Nebiyou Bekele, Maher N Younes, Corazon D Bucana, Isaiah J Fidler,[...]. Clin Cancer Res 2003
40
7

Combinatorial chemoprevention of intestinal neoplasia.
C J Torrance, P E Jackson, E Montgomery, K W Kinzler, B Vogelstein, A Wissner, M Nunes, P Frost, C M Discafani. Nat Med 2000
415
7

A genetic explanation of Slaughter's concept of field cancerization: evidence and clinical implications.
Boudewijn J M Braakhuis, Maarten P Tabor, J Alain Kummer, C René Leemans, Ruud H Brakenhoff. Cancer Res 2003
842
7


Chemoprevention: an essential approach to controlling cancer.
Michael B Sporn, Nanjoo Suh. Nat Rev Cancer 2002
250
7

Cyclooxygenase-2 (COX-2)-dependent and -independent anticarcinogenic effects of celecoxib in human colon carcinoma cells.
Thorsten Jürgen Maier, Karin Schilling, Ronald Schmidt, Gerd Geisslinger, Sabine Grösch. Biochem Pharmacol 2004
144
7

Cyclooxygenase-2 (COX-2) expression in high-risk premalignant oral lesions.
Jon Sudbø, Ari Ristimäki, Jan Erik Sondresen, Wanja Kildal, Morten Boysen, Hanna S Koppang, Albrecht Reith, Björn Risberg, Jahn M Nesland, Magne Bryne. Oral Oncol 2003
49
7


Sulindac targets nuclear beta-catenin accumulation and Wnt signalling in adenomas of patients with familial adenomatous polyposis and in human colorectal cancer cell lines.
E M J Boon, J J Keller, T A M Wormhoudt, F M Giardiello, G J A Offerhaus, R van der Neut, S T Pals. Br J Cancer 2004
147
7


Differential expression of epidermal growth factor receptor in human head and neck cancers.
L D Ke, K Adler-Storthz, G L Clayman, A W Yung, Z Chen. Head Neck 1998
71
7


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.